Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19
Journal of Virology · 2025
DOI: 10.1128/jvi.01384-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von A Dette und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Neuropilin-1, Neuropilin-2, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Autopsy Network, BONFOR, aTyr.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) is associated with hyperinflammation, endothelialitis, hypoxemia, and hypercoagulation, contributing to thrombosis in acute severe and long COVID. While ACE2 is the primary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, its low expression in certain infected cell types suggests alternative co-receptors. Neuropilins (NRP1 and NRP2), widely expressed, have been proposed as co-factors for viral entry. We analyzed NRP1 and NRP2 expression in autopsy tissues from heart, lung, and hematolymphoid organs using immunohistochemistry ( n = 20) and compared findings with public single-cell RNA sequencing (scRNAseq) data. Selected cases were further examined by spatial multiplex immunofluorescence (CODEX). In vitro binding of NRP1/NRP2 to SARS-CoV-2 spike fragments S1 and S1′ was assessed by immunofluorescence microscopy. NRP1 was abundantly expressed in myocardial capillary endothelial cells (ECs) and macrophages in the heart and lung; NRP2 was found in alveolar macrophages and mast cells. scRNAseq re-analysis confirmed these in situ patterns. In vitro , NRP1 exclusively bound S1, while NRP2 bound both S1 and S1′. SARS-CoV-2 RNA was detected in neuropilin-positive, ACE2 / TMPRSS2 -negative vascular EC and mast cells. The detection of SARS-CoV-2 RNA in neuropilin-positive but ACE2 / TMPRSS2 -negative cell clusters supports that neuropilins are involved in systemic viral dissemination. NRP1 on vascular EC may contribute to angiogenesis, vascular damage, and microangiopathy, while NRP2 represents a potential immunomodulatory target to regulate macrophage activity, resolve inflammation, and potentially prevent the progression of pulmonary fibrosis and limit excessive mast cell activation in long COVID. IMPORTANCE The well-known severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, angiotensin-converting enzyme 2 (ACE2), exhibits low expression in key cell types implicated in coronavirus disease 2019 (COVID-19) pathology, such as endothelial cells and B cells, macrophages, and mast cells. In contrast, neuropilins, identified as co-receptors for SARS-CoV-2, are abundantly expressed in these cells under physiological conditions and may be involved in virus-host interactions. This study presents a detailed in situ analysis of Neuropilin 1 (NRP1) and Neuropilin 2 (NRP2) expression in fatal COVID-19 cases using immunohistochemistry and spatial multiplex immunofluorescence phenotyping, complemented by single cell RNA sequencing. Additionally, it demonstrates differential binding affinities of NRP1 and NRP2 to SARS-CoV-2 spike protein fragments S1 and S1′ in vitro , suggesting distinct roles for these neuropilins in viral recognition. This study highlights the impact of the unique furin cleavage site in SARS-CoV-2, which may contribute to increased pathogenicity through its interaction with NRP1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, University Hospital Bonn, Bonn, Germany.
- Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
- Institute of Pathology, Hannover Medical School, Hanover, Germany.
- Institute of Pathology and Department of Molecular Pathology, Helios University Clinic Wuppertal, Wuppertal, Germany.
- Asklepios Medical Care Center Pathology, Gauting, Germany.
- Precipoint Innovation GmbH, Garching, Germany.
ORCID-Profile: A Dette, T Mayr, I Gütgemann
Förderung
- National Autopsy Network
- BONFOR
- aTyr
Zitieren
APA
Dette, A., Moers, F., Mayr, T., Stillfried, S., Bernhardt, M., Förster, S., Werlein, C., Ackermann, M., Muders, M. H., Kristiansen, G., Boor, P., & Gütgemann, I. (2025). Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19. Journal of Virology. https://doi.org/10.1128/jvi.01384-25
Vancouver
Dette A, Moers F, Mayr T, Stillfried S, Bernhardt M, Förster S, et al. Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19. Journal of Virology. 2025. doi:10.1128/jvi.01384-25
BibTeX
@article{Dette2025,
author = {Dette, A and Moers, F and Mayr, T and Stillfried, S V and Bernhardt, M and Förster, S and Werlein, C and Ackermann, M and Muders, M H and Kristiansen, G and Boor, P and Gütgemann, I},
title = {Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.01384-25}
}
EUVIMED